EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the Inflammation–Metabolism Axis in MGUS: Causal Roles of CXCL10 Mediated by Blood Metabolites

Siyu Gu iD, Zhongyuan Wang iD, Zhiyao Wen iD, Mingyuan Fang iD, Long Ye iD, Jie Jiang iD, Haiying Hua iD

Mediators of Inflammation · 2025

DOI: 10.1155/mi/8804923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, 2025. Verfasst von Siyu Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China, jiangnan.edu.cn. Hauptthemen laut MEDLINE: Chemokine CXCL10, Inflammation, Monoclonal Gammopathy of Undetermined Significance. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory cytokines have been implicated in monoclonal gammopathy of undetermined significance (MGUS), but their causal mechanisms remain unclear. Metabolites play pivotal roles in plasma cell dysregulation, however, their potential mediation effects between cytokines and MGUS are unexplored. We aimed to elucidate causal relationships between inflammatory cytokines and MGUS and identify metabolite‐mediated pathways.

Methods

Using genome‐wide association study (GWAS) summary statistics, we performed bidirectional two‐sample Mendelian randomization (MR) to assess causality between 91 inflammatory cytokines and MGUS. A two‐step MR approach was employed to investigate metabolite mediation using data from 1400 blood metabolites. Sensitivity analyses addressed pleiotropy and reverse causality (IVs: p < 1 × 10 −5 , F ‐statistic > 10).

Results

MR analysis identified CXCL10 (OR = 2.12, 95% CI: 1.06–4.23, p = 0.034) and IL‐6 (OR = 3.61, 95% CI: 1.22–10.65, p = 0.020) as causal risk factors for MGUS. We also found Threonate (OR = 2.24, 95% CI: 1.06–4.75, p = 0.035), X‐22776 (OR = 3.45, 95% CI: 1.37–8.67, p = 0.009) and glucose to sucrose ratio (OR = 2.89, 95% CI: 1.18–7.07, p = 0.020) were associated with increased MGUS risk, while N‐acetylputrescine to (N(1) + N(8))‐acetylspermidine ratio (OR = 0.65, 95% CI: 0.43–0.98, p = 0.039) showed protective effects. Mediation analysis revealed 2 metabolites Threonate and X‐22776 mediating CXCL10’s effect on MGUS. Threonate mediated 11.2% ( β = 0.08, p = 0.014) and X‐22776 mediated 17.7% ( β = 0.13, p = 0.028) of CXCL10’s total effect. Sensitivity analyses confirmed robustness (no pleiotropy: MR‐Egger intercept p > 0.05; Cochran’s Q p > 0.05).

Conclusion

This study deeply reveals the mechanism by which inflammatory cytokines affect the pathogenesis of MGUS through metabolite‐mediated pathways, providing new potential targets for the early diagnosis and treatment of MGUS. In the future, other inflammatory cytokines and metabolites that may be related to the pathogenesis of MGUS can be further explored, and the interactions and potential mechanisms between them can be further studied to provide a more comprehensive theoretical basis and practical guidance for the prevention and treatment of MGUS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CXCL10InflammationMonoclonal Gammopathy of Undetermined SignificanceHumansGenome-Wide Association StudyInterleukin-6CytokinesMendelian Randomization Analysis

Stichwörter der Autor:innen

CXCL10IL-6MGUSMendelian randomizationinflammatory cytokinesmetabolic mediators

Substanzen

Chemokine CXCL10Interleukin-6CXCL10 protein, humanCytokines

Autor:innen und Institutionen

  • Department of Hematology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China, jiangnan.edu.cn.
  • Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China, jiangnan.edu.cn.

ORCID-Profile: Siyu Gu, Zhongyuan Wang, Zhiyao Wen, Mingyuan Fang, Long Ye, Jie Jiang, Haiying Hua

Förderung

  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Gu, S., Wang, Z., Wen, Z., Fang, M., Ye, L., Jiang, J., & Hua, H. (2025). Targeting the Inflammation–Metabolism Axis in MGUS: Causal Roles of CXCL10 Mediated by Blood Metabolites. Mediators of Inflammation. https://doi.org/10.1155/mi/8804923

Vancouver

Gu S, Wang Z, Wen Z, Fang M, Ye L, Jiang J, et al. Targeting the Inflammation–Metabolism Axis in MGUS: Causal Roles of CXCL10 Mediated by Blood Metabolites. Mediators of Inflammation. 2025. doi:10.1155/mi/8804923

BibTeX
@article{Gu2025,
  author = {Gu, Siyu and Wang, Zhongyuan and Wen, Zhiyao and Fang, Mingyuan and Ye, Long and Jiang, Jie and Hua, Haiying},
  title = {Targeting the Inflammation–Metabolism Axis in MGUS: Causal Roles of CXCL10 Mediated by Blood Metabolites},
  journal = {Mediators of Inflammation},
  year = {2025},
  doi = {10.1155/mi/8804923}
}
Kostenlos starten →